Crossmark

LINC00852 promotes the proliferation and invasion of ovarian cancer cells by competitively binding with miR-140-3p to regulate AGTR1 expression

Published Online: 2021-09-08

Published Print: 2021-12

Authors

Qiao, Zhi-wei

Jiang, Ying

Wang, Ling

Wang, Lei

Jiang, Jing

Zhang, Jing-ru

Mu, Peng https://orcid.org/0000-0001-6786-5699
Funding

Funding for this research was provided by:

Natural Science Foundation of Liaoning Province (20170540570)
License Information

Text and Data Mining valid from 2021-09-08

Version of Record valid from 2021-09-08
More Information

Article History

Received: 6 December 2020

Accepted: 25 August 2021

First Online: 8 September 2021

Declarations

:

: Written informed consent was obtained from all ovarian cancer patients. All clinical experiments were approved by the institutional ethical review boards of Cancer Hospital of China Medical University. All animal experiments were approved by the Ethics Committee of Cancer Hospital of China Medical University. The number of the ethical approval is SYXK (Liao)2017-0004.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current